Eff Aar Global Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-07-2024
- Paid Up Capital ₹ 1.00 M
as on 30-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 109.26%
(FY 2023)
- Profit -66.80%
(FY 2023)
- Ebitda -195.84%
(FY 2023)
- Net Worth -42.79%
(FY 2023)
- Total Assets 17.12%
(FY 2023)
About Eff Aar Global Healthcare
The Corporate was formerly known as Frprime Global Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abdul Razack, Mohammed Purayil, Abdul Eramangalath, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100KL2019PTC059885
- Company No.
059885
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eff Aar Global Healthcare?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mullambalath Nasar  | Director | 07-Oct-2019 | Current |
| Abdul Razack | Director | 07-Oct-2019 | Current |
| Mohammed Purayil | Director | 07-Oct-2019 | Current |
| Abdul Eramangalath | Director | 07-Oct-2019 | Current |
| Mohamed Saif | Director | 07-Oct-2019 | Current |
Financial Performance of Eff Aar Global Healthcare.
Eff Aar Global Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.26% increase. The company also saw a substantial fall in profitability, with a 66.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eff Aar Global Healthcare?
In 2023, Eff Aar Global Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Koduvally Institute Of Medical Sciences Private LimitedActive 14 years 8 monthsAbdul Razack is a mutual person
Frprime Ventures LlpActive 7 years 4 monthsAbdul Razack, Mohammed Purayil and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eff Aar Global Healthcare?
Unlock and access historical data on people associated with Eff Aar Global Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eff Aar Global Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eff Aar Global Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
